Guangdong Jiaying Pharmaceutical Co Ltd (002198) — Working Capital to Net Assets Ratio

Latest as of March 2026: 56.7%

Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a Working Capital to Net Assets ratio of 56.7% as of March 2026. Working capital of CN¥414.15 Million (current assets of CN¥541.63 Million minus current liabilities of CN¥127.48 Million) is measured against net assets of CN¥730.39 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Guangdong Jiaying Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.

WC/NA Ratio

56.7%
Working Capital / Net Assets

Working Capital

CN¥414.15 Million
CNY

Current Assets

CN¥541.63 Million
CNY

Current Liabilities

CN¥127.48 Million
CNY

Guangdong Jiaying Pharmaceutical Co Ltd Working Capital to Net Assets (2004–2025)

This chart shows how Guangdong Jiaying Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2004 to 2025. As of March 2026, the ratio stands at 56.7%, reflecting working capital of CN¥414.15 Million against net assets of CN¥730.39 Million CNY. Check 002198 tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 002198 market cap overview.

Year WC/NA Ratio Working Capital (CNY) Net Assets Current Assets Current Liabilities Change (pp)
2025 56.6% CN¥406.29 Million CN¥717.93 Million CN¥502.68 Million CN¥96.38 Million ▼ -10.4 pp
2024 67.0% CN¥508.19 Million CN¥758.22 Million CN¥553.76 Million CN¥45.57 Million ▼ -2.5 pp
2023 69.6% CN¥530.83 Million CN¥762.98 Million CN¥580.17 Million CN¥49.34 Million ▲ +4.4 pp
2022 65.1% CN¥474.49 Million CN¥728.42 Million CN¥557.43 Million CN¥82.95 Million ▲ +6.4 pp
2021 58.7% CN¥401.76 Million CN¥684.48 Million CN¥489.67 Million CN¥87.91 Million ▲ +8.3 pp
2020 50.4% CN¥344.06 Million CN¥683.01 Million CN¥434.52 Million CN¥90.46 Million ▲ +12.5 pp
2019 37.9% CN¥251.50 Million CN¥663.17 Million CN¥409.26 Million CN¥157.76 Million ▼ -4.8 pp
2018 42.7% CN¥335.31 Million CN¥785.35 Million CN¥404.48 Million CN¥69.16 Million ▲ +5.3 pp
2017 37.4% CN¥280.68 Million CN¥749.81 Million CN¥372.25 Million CN¥91.57 Million ▲ +9.9 pp
2016 27.5% CN¥270.98 Million CN¥984.87 Million CN¥350.61 Million CN¥79.64 Million ▲ +4.9 pp
2015 22.6% CN¥210.29 Million CN¥929.70 Million CN¥293.84 Million CN¥83.55 Million ▲ +3.3 pp
2014 19.3% CN¥166.82 Million CN¥863.35 Million CN¥304.01 Million CN¥137.19 Million ▼ -5.0 pp
2013 24.4% CN¥197.26 Million CN¥809.66 Million CN¥271.86 Million CN¥74.60 Million ▲ +5.7 pp
2012 18.7% CN¥52.03 Million CN¥278.08 Million CN¥88.20 Million CN¥36.17 Million ▲ +6.6 pp
2011 12.1% CN¥32.70 Million CN¥270.51 Million CN¥68.74 Million CN¥36.04 Million ▼ -5.6 pp
2010 17.7% CN¥45.84 Million CN¥258.47 Million CN¥80.74 Million CN¥34.90 Million ▼ -10.5 pp
2009 28.2% CN¥68.06 Million CN¥241.42 Million CN¥79.97 Million CN¥11.91 Million ▼ -37.9 pp
2008 66.1% CN¥149.56 Million CN¥226.35 Million CN¥158.45 Million CN¥8.89 Million ▼ -7.8 pp
2007 73.8% CN¥156.98 Million CN¥212.62 Million CN¥189.84 Million CN¥32.85 Million ▲ +37.0 pp
2006 36.8% CN¥30.40 Million CN¥82.63 Million CN¥67.82 Million CN¥37.42 Million ▲ +15.8 pp
2005 21.0% CN¥13.52 Million CN¥64.39 Million CN¥40.36 Million CN¥26.84 Million ▲ +31.0 pp
2004 -10.0% CN¥-4.88 Million CN¥48.97 Million CN¥18.07 Million CN¥22.95 Million
pp = percentage points